TheEdgeResearch
Home / Stocks / ANIP

ANI Pharmaceuticals, Inc. (ANIP)

NASDAQ Healthcare Drug Manufacturers - Specialty & Generic
$68.55 ▼ -0.84%
Market Cap
$1.56B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.47
52-Wk Range
67.14-87.76
CEO
Nikhil Lalwani
Country
US
Currency
USD

ANI Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Princeton, NJ, US. The stock last traded at $68.55, down 0.84% on the session, giving a market capitalisation of $1.56B. On trailing twelve-month figures it carries a trailing P/E of 13.23, a net margin of 11.2%. Its beta of 0.47 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
13.23
Price / Sales
1.50
Price / Book
2.28
EV / EBITDA
5.30
Gross margin
67.8%
Operating margin
17.3%
Net margin
11.2%
Return on equity
—
Debt / equity
0.47
Current ratio
2.75
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ
Employees
970
IPO date
2000-05-05
Headquarters
Princeton, NJ, US
About ANI Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Comparable companies

ANI Pharmaceuticals, Inc. is most often compared with the following Healthcare names:

AMPHAMRXBHCCOLLEOLSHROWLFCRRDYTEVAVTRS
More research on ANIP
ANIP technical analysis ANIP TheEdge Score Compare against peers
Open full interactive analysis & DCF →